According to their website Delmedica Investments, based in Singapore, is a specialist funding company offering investors access to the immense potential of the global biotechnology industry. They claim that via their impressive resources and network of health care professionals, Delmedica identifies new opportunities with tangible commercial potential, opportunities that supposedly represent low risk, high-growth and clear exit strategies.